ID   20B8
AC   CVCL_6347
DR   CLO; CLO_0001191
DR   ATCC; CRL-12582
DR   BioSample; SAMN03471346
DR   Wikidata; Q54583114
RX   Patent=US6358703;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12582.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3546; F8 (Note=With p.Ser765_Asn1658del = BDD-FVIII).
CC   Discontinued: ATCC; CRL-12582; true.
ST   Source(s): ATCC=CRL-12582
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D5S818: 8,9,12
ST   D7S820: 10,11
ST   TH01: 7,9,9.3
ST   TPOX: 6,11
ST   vWA: 15,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3712 ! HKB-11
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
RX   Patent=US6358703;
RA   Cho, Myung-Sam
RA   Chan, Sham-Yuen
RA   Kelsey, William
RA   Yee, Helena
RT   "Expression system for factor VIII.";
RL   Patent number US6358703, 19-Mar-2002.
//